EUVIMEDEUVIMED entdecken
Open Access

Evaluating Cost-Effectiveness in Using High-Kidney Donor Profile Index Organs

Trevor A Ellison, Sunjae Bae, Eric K H Chow, Allan B Massie, Lauren M Kucirka, Kyle J Van Arendonk, Dorry L Segev

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.09.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Trevor A Ellison und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Genesis Healthcare, Zanesville, OH. Electronic address: trevorellison@gmail.com. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A more granular donor kidney grading scale, the kidney donor profile index (KDPI), has recently emerged in contradistinction to the standard criteria donor/expanded criteria donor framework. In this paper, we built a Markov decision process model to evaluate the survival, quality-adjusted life years (QALY), and cost advantages of using high-KDPI kidneys based on multiple KDPI strata over a 60-month time horizon as opposed to remaining on the waiting list waiting for a lower-KDPI kidney. Data for the model were gathered from the Scientific Registry of Transplant Recipients and the United States Renal Data System Medicare parts A, B, and D databases. Of the 129,024 phenotypes delineated in this model, 65% of them would experience a survival benefit, 81% would experience an increase in QALYs, 87% would see cost-savings, and 76% would experience cost-savings per QALY from accepting a high-KDPI kidney rather than remaining on the waiting list waiting for a kidney of lower-KDPI. Classification and regression tree analysis (CART) revealed the main drivers of increased survival in accepting high-KDPI kidneys were wait time ≥30 months, panel reactive antibody (PRA)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationAgedHumansUnited StatesCost-Benefit AnalysisGraft SurvivalMedicareKidneyTissue DonorsRetrospective Studies

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Genesis Healthcare, Zanesville, OH. Electronic address: trevorellison@gmail.com.
  • Department of Surgery, NYU Grossman School of Medicine, NY; Department of Population Health, NYU Grossman School of Medicine, NY.
  • Rosalind Franklin University of Medicine and Science, North Chicago, IL.
  • Department of Obstetrics and Gynecology, University of North Carolina, NC.
  • Department of Surgery, Division of Pediatric Surgery, Medical College of Wisconsin, WI.

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Ellison, T. A., Bae, S., Chow, E. K. H., Massie, A. B., Kucirka, L. M., Van Arendonk, K. J., & Segev, D. L. (2023). Evaluating Cost-Effectiveness in Using High-Kidney Donor Profile Index Organs. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.09.026

Vancouver

Ellison TA, Bae S, Chow EKH, Massie AB, Kucirka LM, Van Arendonk KJ, et al. Evaluating Cost-Effectiveness in Using High-Kidney Donor Profile Index Organs. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.09.026

BibTeX
@article{Ellison2023,
  author = {Ellison, Trevor A and Bae, Sunjae and Chow, Eric K H and Massie, Allan B and Kucirka, Lauren M and Van Arendonk, Kyle J and Segev, Dorry L},
  title = {Evaluating Cost-Effectiveness in Using High-Kidney Donor Profile Index Organs},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.09.026}
}
Kostenlos starten →